Abstract
The toxicity profile of silodosin, a selective alpha(1A)-adrenoceptor antagonist, was evaluated. The lethal doses were 800 mg/kg in rats and 1500 mg/kg in dogs. Repeated-dose studies revealed fatty degeneration of hepatocytes and an induction of drug-metabolizing enzymes at 15 mg/kg/day or more in male rats, mammary gland hyperplasia at 60 mg/kg/day or more in female rats, and degeneration of the seminiferous tubular epithelium at 25 mg/kg/day or more only in young dogs. Silodosin was negative in all mutagenicity studies, except for a weak positive in a chromosomal aberration assay conducted without metabolic activation. In carcinogenicity studies, mammary gland tumors and pituitary adenomas were increased in female mice given 150 mg/kg/day or more and 400 mg/kg/day respectively, while thyroid follicular cell carcinoma was increased in male rats given 150 mg/kg/day. Reproductive studies in rats revealed a decreased male fertility at 20 mg/kg/day or more and a prolonged estrous cycle at 60 mg/kg/day or more. Silodosin did not exhibit any teratogenic potential in either rats or rabbits, and had no effects on the postnatal development of rat offspring. In safety pharmacology studies, silodosin produced no severe effects on the cen...Continue Reading
References
Feb 1, 1975·Endocrinology·D M Lawson, R R Gala
Jan 1, 1991·Adverse Drug Reactions and Toxicological Reviews·R BassJ Manson
Apr 1, 1990·Contraception·W D Ratnasooriya, R M Wadsworth
Apr 1, 1989·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·E J de Castro e Silva, J Antunes-Rodrigues
May 1, 1989·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·R N HillC F Wilkinson
Jan 1, 1988·Reproductive Toxicology·R J Levine
Dec 14, 1968·Nature·G M HahnV Parker
Sep 1, 1983·Archives of Toxicology·S Alder, G Zbinden
Feb 27, 1984·The American Journal of Medicine·E Dall'AglioG M Reaven
Jul 1, 1994·Andrologia·M RyanR F Harrison
Mar 1, 1993·Journal of Clinical Pharmacology·S W Rabkin
Jan 1, 1997·Toxicologic Pathology·C C Capen
Jan 4, 1998·Pharmacology, Biochemistry, and Behavior·A G NaselloL F Felicio
Oct 12, 1999·Endocrine-related Cancer·B K Vonderhaar
Jan 14, 2000·Mutation Research·D J Kirkland, L Müller
Mar 29, 2000·Environmental and Molecular Mutagenesis·S M Galloway
May 29, 2002·Fundamental & Clinical Pharmacology·Gerd BodeUNKNOWN ICH Expert Working Group
Jul 2, 2003·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Munehiro Hashimoto
Nov 6, 2003·Toxicology·Maritha Marcusson-Ståhl, Karin Cederbrant
Feb 24, 2006·Journal of Pharmacological Sciences·Hiroyuki TashibuKeiji Yamamoto
Oct 6, 2011·Mutation Research·S H DoakN Singh
Citations
Apr 11, 2008·The Journal of Sexual Medicine·Ko KobayashiTaiji Tsukamoto
Jan 28, 2010·The Journal of Sexual Medicine·Fumitaka ShimizuMakoto Fujime
Feb 18, 2009·BJU International·Makoto YonoMasaki Yoshida